ABsTrACT
Objectives recent studies indicate that glucose metabolism is altered in rheumatoid arthritis (rA) fibroblast-like synoviocytes (FLS). Hexokinases (HKs) catalyse the first step in glucose metabolism, and HK2 constitutes the principal HK inducible isoform. We hypothesise that HK2 contributes to the synovial lining hypertrophy and plays a critical role in bone and cartilage damage. Methods HK1 and HK2 expression were determined in rA and osteoarthritis (oA) synovial tissue by immunohistochemistry. rA FLS were transfected with either HK1 or HK2 sirnA, or infected with either adenovirus (ad)-GFp, ad-HK1 or ad-HK2. FLS migration and invasion were assessed. to study the role of HK2 in vivo, 10 8 particles of ad-HK2 or ad-GFp were injected into the knee of wild-type mice. K/Bxn serum transfer arthritis was induced in HK2 F/F mice harbouring Col1a1-Cre (HK2 Col1 ), to delete HK2 in non-haematopoietic cells. results HK2 is particular of rA histopathology (9/9 rA; 1/8 oA) and colocalises with FLS markers. Silencing HK2 in rA FLS resulted in a less invasive and migratory phenotype. Consistently, overexpression of HK2 resulted in an increased ability to migrate and invade. It also increased extracellular lactate production. Intra-articular injection of ad-HK2 in normal knees dramatically increased synovial lining thickness, FLS activation and proliferation. HK2 was highly expressed in the synovial lining after K/Bxn serum transfer arthritis. HK2 Col1 mice significantly showed decreased arthritis severity, bone and cartilage damage. Conclusion HK2 is specifically expressed in rA synovial lining and regulates FLS aggressive functions. HK2 might be an attractive selective metabolic target safer than global glycolysis for rA treatment.
InTrOduCTIOn
Rheumatoid arthritis (RA) is a systemic autoimmune disease that leads to chronic inflammation and progressive joint destruction. 1 One of the apparent histopathological changes of the joint in RA is the hypertrophic synovial lining. 2 3 Fibroblast-like synoviocytes (FLS) are stromal cells that give structure to the synovial lining and are contributing to RA pathology by invading and promoting cartilage destruction, expressing metalloproteases (MMP) and inducing chronic inflammation by secreting pro-inflammatory cytokines and chemokines. 2 4 5 There is an unmet need to target FLS aggressive phenotype in RA in combination with current therapies. Different approaches have highlighted underlying mechanisms that explain RA FLS behaviour, including activation of signalling pathways 6 7 , and epigenetic modifications. 8 9 RA FLS metabolism has gained attention as recent studies have pointed out to modifications in RA FLS cell metabolism. 3 10 Many key signalling pathways that are activated by the inflamed joint microenvironment converge to adapt cell metabolism in order to support FLS activation and aggressive phenotype, suggesting that the study of metabolic changes in RA FLS and key players could potentially lead to the identification of new therapeutic agents. 3 10-12 Among other metabolic changes, our recent work and others have highlighted a critical role of glucose metabolism in activated FLS. 13 14 The high level of activity in glycolytic inflamed tissues is manifested by the use of positron emission tomography (PET), which can be observed by PET in swollen joints. 15 16 Also, synovial fluid from patients with RA has higher levels of lactate and less glucose levels than osteoarthritis (OA) synovial fluid. 17 18 This dependency of activated cells on accelerated glucose metabolism could render them more vulnerable to the disruption of glucose metabolism and support that targeting glucose metabolism might be a reasonable complementary approach for patients with RA.
11
Hexokinases (HKs) catalyse the first committed step in glucose metabolism. 19 20 By catalysing the phosphorylation of glucose to G6P, hexokinases promote and sustain a concentration gradient that facilitates glucose entry into cells and the initiation of all major pathways of glucose utilisation. HK1 is constitutively expressed in most mammalian adult tissues. HK2, which also has high affinity for glucose and harbours two catalytic domains, constitutes the principal inducible isoform. 21 The identification of isoform-specific contributors to elevated cell glucose metabolism without compromising systemic homeostasis or normal metabolic functions could make targeting cell metabolic changes an approach more feasible.
Here, we test the hypothesis that HK2 is a specific isoform contributing to elevated cell glucose metabolism in RA FLS and is a key regulator of aggressive FLS phenotype. We show that HK2 expression is elevated in the RA synovial tissue and overexpression of HK2 in the murine synovial lining promotes hypertrophy of healthy synovium as well as RA FLS activation. HK2 deletion in FLS decreases its aggressive phenotype, and HK2 deletion in Col1a1-expressing cells ameliorates disease severity of arthritis. Taken together, our data suggest that HK2 is involved in FLS activation and synovial hypertrophy and could play a role in RA.
MeTHOds

Human synovium and FLs
Human synovium or FLS were extracted from patients with RA or OA undergoing total joint replacement. All patients with RA met the American College of Rheumatology 1987 revised criteria for seropositive RA as previously described. 22 23 FLS were used between p4 and p9 passages.
More detailed methods are provided as online supplementary methods.
resuLTs
HK2 expression is mainly induced in the inflamed synovial lining of patients with rA
We first studied the expression of both HK isoforms in synovium to determine whether or not HK2 is an inducible isoform in synovial tissue. Immunohistochemistry (IHC) analysis of HK2 expression in RA synovium revealed that HK2 was detected in RA synovial tissue, very predominant in the lining but also in sublining ( figure 1A ). Of interest, while HK2 expression was abundant in all RA synovial samples tested (nine different RA donors), both lining and sublining were negative for HK2 expression in most OA synovial samples (seven out of eight different OA donors) ( figure 1A ). HK1 expression, as expected, was uniformly present in both OA and RA synovial tissue (online supplementary figure 1A ). Of note, when cultured in vitro, both RA and OA FLS cell lines expressed HK2 at basal level, although HK2 expression level was higher in RA than in OA FLS (online supplementary figure 1B) .
We then performed a double-colour IHC to determine whether or not FLS expressed HK2 in the RA synovium. We identified FLS as cells positive for vimentin, vascular cell adhesion protein 1 (VCAM1) or podoplanin (PDPN). 2 24 As shown in figure 1B, HK2-positive staining colocalised with all the different FLS markers in the lining. Of interest, other cells in the sublining of some RA samples, which were negative for FLS markers, did expressed HK2, suggesting that other synovial cell types could also upregulate HK2 expression in RA synovial tissue.
effect of HK2 modulation in aggressive functions of human FLs
In order to investigate the role of HK2 in RA FLS functions, we conducted in vitro studies. We first studied whether inflammatory mediators implicated in FLS inflammatory response upregulated HK2 expression. As shown in figure 1C , D, stimulation of RA FLS with platelet-derived growth factor (PDGF), lipopolysaccharide (LPS), tumour necrosis factor (TNF) or hypoxia increased the expression of HK2 protein. TNF and hypoxia stimulation also increased HK2 protein levels in OA FLS (online supplementary figure 1C ). We then silenced HK1 and HK2 expression in those cell lines. Online supplementary figure 2A , B shows HK1 and HK2 expression by qPCR and immunoblotting (IB) after HK silencing in RA FLS. As glycolysis inhibition was shown to induce cell death in FLS, 25 we confirmed that HK1 or HK2 silencing did not change cell viability or shape (online supplementary figure 2C ). As shown in figure 2A , RA FLS after HK silencing were less invasive (HK1: p<0.001; HK2: p<0.05) and migration measured by the length of the scar was also diminished (HK1: p<0.0001; HK2 p<0.001). Yet, HK silencing did not modify interleukin (IL)-6, IL-8 or MMP expression (online supplementary figure 2D ).
Basic and translational research
We also tested the effect of HK2 overexpression in RA FLS by infecting with adenovirus carrying human HK1 or HK2 (ad-huHK1 or ad-huHK2). Online supplementary figure 3A and B shows HK1 and HK2 expression by qPCR and IB after ad-HK infection in RA FLS. After HK2 overexpression, RA FLS were more invasive than after HK1 overexpression (HK2: p=0.01, figure 2B ). HK2 overexpression also decreased the length of the scar in the migration assay in FLS although did not reach significance (figure 2B), and increased RNA levels of the pro-inflammatory cytokine IL-6, IL-8 and MMP ( figure 2C ). Yet, it did not induce any change in proliferation (online supplementary figure 3C) Interestingly, both HK1 and HK2 overexpression increased RA FLS extracellular lactate production but only HK2 overexpression also increased GLUT1 mRNA levels ( figure 2D ). Yet, inhibition of the extracellular lactate transporters after HK2 overexpression by 7AAC, which specifically inhibits monocarboxylate transporter 1 and 4 (MTC1/4), did not abolish HK2 invasive phenotype in RA FLS (figure 2E).
HKs can bind to mitochondria through their N-terminal hydrophobic regions. Confocal studies were conducted to determine HKs intracellular distribution in FLS. Of interest, these studies showed that the distribution of HKs in non-infected FLS was different between HK1 and HK2. While HK1 was colocalised with or adjacent to mitochondria, HK2 was only partially mitochondria-bounded and it also displayed diffuse cytoplasmic distribution ( figure 3A and online supplementary figure  4) . Notably, after HK1 overexpression, the intensity of HK1 colocalisation with mitochondria and mitochondria distribution differed considerably from HK2 distribution and colocalisation after HK2 overexpression, which may explain the discrepancies observed after HK1 and HK2 overexpression ( figure 3A and  online supplementary figure 4) .
We finally addressed whether HK2 overexpression could induce an inflammatory phenotype in OA FLS. As shown in figure 3B , overexpression of HK2 induced an increase of RNA levels of the pro-inflammatory cytokine IL-6, IL-8 and MMP in OA cell lines. Of interest, the overexpression of HK2 induced an invasive phenotype compared with ad-GFP but not in all OA FLS cell lines tested. As opposed to the homogeneity of the HK2 overexpression effect on RA FLS, the invasive phenotype after HK2 overexpression varied among OA FLS cell lines (figure 3C), and overall quantification ( figure 3D ) did not show significant differences, suggesting that HK2 expression contributes but is not sufficient to completely recapitulate the aggressive phenotype of RA FLS.
HK2 overexpression leads to a synovial lining hypertrophy in murine healthy joints
In order to assess the effect of HK2 overexpression in synovial tissue in vivo, we intra-articularly injected adenovirus carrying murine HK2 (ad-mHK2) into murine knees, and adenovirus carrying GFP (ad-GFP) as a control in the contralateral knee of wild-type (WT) healthy mice. Overexpression of HK2 in the synovial lining was effective since HK2 expression was increased in ad-mHK2-injected joints compared with ad-GFP-injected joints ( figure 4A ). Interestingly, we observed that intra-articular injection of ad-mHK2 in normal knees dramatically increased synovial lining thickness (mean±SEM: ad-GFP: 0.54±0.21; ad-HK2: 2.91±0.28; p<0.00001) (figure 4B). We also observed synovial lining from ad-HK2-injected knee migrating towards the cartilage compared with ad-GFP-injected knees (mean±SEM: ad-GFP: 0.75±0.22; ad-HK2: 2.03±0.29; p=0.0015) (figure 4B). Double-colour IHC with vimentin confirmed HK2 expression in FLS after ad-mHK2 injection (figure 4C).
We then tested if HK2 overexpression modified FLS activation and proliferation by staining for anti-alpha smooth muscle actin (α-sma), a myofibroblastic marker, MMP3 and Ki67, a marker of proliferative cells. Figure 4D shows that anti α-sma staining was increased in ad-mHK2-injected knees compared with ad-GFP-injected knees. MMP3 staining was also widely present in the hypertrophic lining in ad-mHK2 synovium ( figure 4D ). Of interest, intra-articular injection of ad-mHK2 also increased the number of positive Ki67 cells in the synovium (figure 4E) We also determined whether the overexpression of ad-mHK2 in the lining induced the recruitment of infiltrating cells. Although the response was more heterogeneous than the synovial hypertrophy induction by HK2 overexpression, we observed a mild sublining infiltration in 6 out of 13 knees after ad-mHK2 injection compared with none after ad-GFP injection (mean±SEM: ad-GFP: 0.08±0.08; ad-HK2: 0.92±0.29; p=0.02) (figure 4G). When observed at higher magnification, most of the infiltrating cells were mononuclear cells ( figure 4G ). We then stained for F4/80, a marker of monocyte-macrophage lineage, and for iNOS, which stains activated myeloid cells. We observed that both sublining infiltrating cells were positive for F4/80 and iNOS. Double-colour IHC with vimentin and iNOS confirmed that most of vimentin-positive cells were negative for iNOS, suggesting that the infiltrating cells were indeed activated myelomonocitic cells ( figure 4H ).
Basic and translational research
HK2 expression in murine joints is also increased in synovial FLs after arthritis induction
The effect of HK2 on FLS migration and invasion led us to evaluate the role of HK2 in the K/BxN arthritis model. The K/BxN passive serum transfer model is FLS dependent and requires only innate immunity. 26 27 PDPN, glycoprotein highly expressed in activated RA FLS, is also expressed in the arthritic murine lining (figure 5A). As we recently published, 14 several genes related to glucose metabolism were upregulated early in the course of the arthritis, at day 5 after K/BxN serum transfer, in enriched arthritic CD45 neg PDPN pos cells. We confirmed that HK2 expression had higher expression in enriched arthritic CD45
neg PDPN pos cells (1.04±0.4 in normal joints vs 1.8±0.3 in figure 5D, E) . Specifically, GLUT1, ENO1 but also pyruvate kinase muscle isoenzyme 2, pyruvate dehydrogenase kinase (PDK) 1 and 3 were upregulated in this population.
Conditional knockout of HK2 in Col1a1-expressing cells has an ameliorated arthritic disease
As there is no available Cre-recombinase expressing strain that deletes specifically in FLS, we generated HK2F/F Col1a1-Cre (HK2 Col1 ) mice to delete HK2 in collagen type I expressing cells including FLS. As shown in figure 6A , HK2 was deleted in HK2 Col1 joint FLS. We then conducted the arthritic model of K/BxN serum-transfer arthritis. Deletion of HK2 in Col1a1 expressing cells significantly decreased arthritis severity (clinical score at day 12 was 9±2.5 in WT mice vs. 6.1±3.2 in HK2 F/ F Col1a1-Cre; p=0.02) ( figure 6B) . Histopathological studies at day 12 showed that bone erosion (p=0.04) and cartilage damage (p=0.05), but not less cellular infiltration was reduced in HK2
Col1 mice compared with littermate control (figure 6C, D). Of note, MMP3 and Ki67 expression that were upregulated in K/BxN arthritis synovium were decreased in HK2 Col1 mice compared with littermate control (figure 6E).
dIsCussIOn
The concept of metabolic reprogramming to improve immunotherapy slowly is being translated into autoimmune diseases to complement current therapies. 28 Yet, there are little data about targeting metabolic changes in RA. We here showed that targeting the first step in glucose metabolism could be a potential selective metabolic therapy for RA and regulates FLS aggressive behaviour.
Although previous works have demonstrated a role of glucose metabolism in cell activation and function, [29] [30] [31] inhibiting general glucose metabolism is not desirable in the overall body. Thus, there is a need of finding specific metabolic targets that are induced in activated cells such as FLS. HKs are the first enzymatic step in glucose metabolism. While HK1 is a ubiquitously expressed enzyme in all living cells, HK2 is an inducible form and only expressed in adulthood in some organs. Our data suggest that HK2 constitutes an attractive potential selective Basic and translational research target for arthritis therapy. Indirect evidence of HK2 redundancy in adulthood is the fact that global HK2 ablation in adult mice was well tolerated, and HK2-deficient mice were indistinguishable from control mice both morphologically, and in terms of growth, bodyweight and glucose homeostasis. 19 Adult tissues that abundantly express HK2 also express relatively high levels of HK1, which might play a compensatory or redundant role in the absence of HK2.
Here, we have observed that HK2 is not expressed in most of OA patient's synovial tissue. Consistent with the idea of upregulation secondary to synovial inflammation, we observed that its expression was induced by inflammatory and activation signals including LPS, PDGF, TNF and hypoxia. In K/BxN model of mice, its expression is also elevated in inflamed joints but not in healthy joints. Interestingly, HK2 mRNA expression levels are also increased in TNF or IL-1β-stimulated RA FLS as published in Geo Datasets (Array GSE49604, GSE516, GSE2676), together with other glucose metabolism related genes. While both HK1 and HK2 silencing reduced migratory and invasive phenotype of RA FLS, only the overexpression of HK2 contributed to aggressive phenotype of FLS since its overexpression increased the invasiveness of these cells and induced IL-6, MMPs and IL-8 mRNA expression. Other studies performed in cancer cells observed similar effects. When HK2 was silenced, breast cancer cells were less migratory after in vitro TNF stimulation, 32 and pancreatic cells were less metastatic in an in vivo model. 33 Although extracellular lactate was shown to be involved in cancer cell invasive phenotype, 33 in RA FLS, the inhibition of lactate transporters (MTC1 and 4) did not reverse the HK2-dependent invasive phenotype. Interestingly, although both HK2 and HK1 similarly increase extracellular lactate, only HK2 and not HK1 overexpression triggers a FLS aggressive phenotype, suggesting the involvement of glycolysis independent mechanisms. Confocal studies revealed that HK1 and HK2 differ in their intracellular colocalisation, but further mechanistic studies are warranted. Of note, HK2 deletion was not sufficient to modulate IL-6 or TNF expression, which might indicate that targeting HK2 will not change pro-inflammatory cytokine profile and could potentially complement current immunotherapies.
In addition, HK2 overexpression in the synovium of a healthy murine knee transformed the thin lining into a hypertrophic synovium and it also enhanced FLS activation and migration towards cartilage. HK2, therefore, led a healthy normal synovial lining into a hypertrophic and aggressive synovium upregulating α-sma and MMP3 expression, and also stimulating proliferation as shown by the presence of Ki67 cells in vimentin positive cells. Yet, HK2 overexpression did not increase proliferation in vitro, suggesting that other mediators are involved in the proliferation observed in the in vivo experiments. The myofibroblastic marker α-sma might explain the migratory phenotype since α-sma has been associated with higher contractile profile in fibroblasts. 34 Whether or not HK2 also plays a role in synovial macrophage recruitment, activation and differentiation requires further studies. Although double-colour IHC showed that most of HK2-positive cells colocalised with vimentin-positive cells, suggesting FLS HK2 involvement in recruiting and activating synovial macrophages, we cannot rule out a direct activation of macrophages by the ad-HK2.
Partial ablation of HK2 in FLS slightly ameliorated the clinical signs of arthritis animal model. We did not see a significant effect on inflammation, probably because as shown in vitro, deletion of HK2 in FLS was not sufficient to modulate the expression of inflammatory mediators. Yet, histological scores of bone and cartilage damage were significantly improved in HK2 Col1 mice, suggesting a predominant role of HK2 in synovial migration and invasion. Col1a1-Cre does not delete only in FLS so the effect of HK2 deletion in other cells including chondrocytes and osteoblasts needs further attention. Although our conditional mice explains the effect of HK2 in non-haematopoietic cells, doublestaining IHC suggest that human RA synovial cells other than FLS also expresses HK2, so further experiments are needed to study the effect of HK2 in other synovial cell types. This is the first study to identify an isoform-specific contributor to metabolism changes in RA synovial tissue that could be selectively targeted without compromising systemic homeostasis or corresponding metabolic functions in normal cells, offering a safer and novel additional approach for combination therapy in RA joint disease independent of systemic immunosuppression. Given HK2 selective overexpression in RA inflamed synovium, and its restricted distribution of expression in normal adult tissues, HK2 constitutes an attractive potential selective target for arthritis therapy and safer than global glycolysis inhibition. 
